Director Robert Baltera Jr. filed a Form 4 with the SEC on November 19, 2026, disclosing an open-market purchase of 50,000 shares of Palisade Bio, Inc. common stock on November 17, 2026.
Key Highlights
- Reporting person: Robert Baltera Jr., listed as a Director of Palisade Bio, Inc.
- Transaction: Purchase (transaction code P) of 50,000 shares of common stock on November 17, 2026.
- Weighted average price: $1.0057 per share, with individual transaction prices ranging from $0.9946 to $1.02.
- Resulting ownership: 511,904 shares of common stock held directly following the transaction.
- Filing date: November 19, 2026, signed by Ryker Willie as Attorney-in-Fact for Robert Baltera Jr.
Palisade Bio Director Robert Baltera Jr. Discloses Open-Market Stock Purchase
According to the Form 4 filing, Robert Baltera Jr., a director of Palisade Bio, Inc. (NASDAQ:PALI), acquired 50,000 shares of the company's common stock on November 17, 2026. The shares were purchased directly and are reported as acquired (code "A") in Table I of the filing.
The filing reports a weighted average purchase price of $1.0057 per share. A footnote in the filing states that "the shares were purchased in multiple transactions at prices ranging from $0.9946 to $1.02." The footnote further states that Baltera Jr. "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
Following the reported transaction, Baltera Jr.'s direct beneficial ownership of Palisade Bio common stock stands at 511,904 shares, according to the filing. No derivative securities transactions were reported in Table II. The Form 4 was signed on November 19, 2026, by Ryker Willie, identified as Attorney-in-Fact for Robert Baltera Jr.
What Was Disclosed
The filing disclosed a director-level open-market purchase of 50,000 shares of Palisade Bio common stock at a weighted average price of $1.0057 on November 17, 2026, bringing the director's total direct holdings to 511,904 shares.



Please wait processing your request...